Founded in 1967, Interpat is the biopharmaceutical Intellectual Property think tank that supports policymakers and world-leading companies who are committed to finding innovative ways to design and deliver products that meet global healthcare challenges. Their objective is to incubates new ideas to help foster innovation and promote effective Intellectual Property (IP) protection as a key incentive for sustainable innovation to advance global health.